Immunization stress-related responses presenting as psychogenic non-epileptic seizures following HPV vaccination in Rio Branco, Brazil

Carregando...
Imagem de Miniatura
Citações na Scopus
18
Tipo de produção
article
Data de publicação
2020
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCI LTD
Autores
PROENCA, Inah Carolina Galatro Faria
MARANHAO, Ana Goretti Kalume
OLIVEIRA, Maria Tereza da Costa
OLIVEIRA, Lucia Helena de
Citação
VACCINE, v.38, n.43, p.6714-6720, 2020
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Importance: The absence of a positive diagnosis of psychogenic non-epileptic seizures (PNES) in immunization stress-related response (ISRR) clusters may have not only a direct impact on affected patients' health but may also reduce compliance to national vaccination programs. It is therefore crucial to develop efficient diagnostic tools and a feasible proposal for proper communication and treatment of ISRR. Purpose: To explore the psychogenic nature of patients' convulsive seizures in a suspected outbreak of an ISRR cluster following human papillomavirus vaccination in Rio Branco, Brazil. Methods: Twelve patients with convulsive seizures were submitted to prolonged intensive videoelectroencephalography monitoring, brain magnetic resonance imaging, cerebrospinal fluid diagnostic testing, laboratory subsidiary examinations, and complete neurological and psychiatric evaluations. Results: Ten patients received the positive diagnosis of PNES, and two patients received the diagnosis of idiopathic generalized epilepsy. No biological association was found between the HPV vaccine and the clinical problems presented by the patients. Conclusions: Prolonged VEEG monitoring can contribute significantly to the positive diagnosis of PNES in ISRR clusters and to avoid hesitancy to vaccinate.
Palavras-chave
HPV vaccination, HPV immunization, Psychogenic non-epileptic seizures, Immunization stress-related response, Immunization anxiety-related reaction, Mass psychogenic illness
Referências
  1. Barcellos C., 2019, PROFISSAO REPORTER N
  2. Bartholomew RE, 2002, BRIT J PSYCHIAT, V180, P300, DOI 10.1192/bjp.180.4.300
  3. Bartholomew RE, 2012, J ROY SOC MED, V105, P509, DOI 10.1258/jrsm.2012.120053
  4. Benbadis SR, 2009, EPILEPSY BEHAV, V15, P106, DOI 10.1016/j.yebeh.2009.02.002
  5. Boss LP, 1997, EPIDEMIOL REV, V19, P233, DOI 10.1093/oxfordjournals.epirev.a017955
  6. Camargo L., 2019, NEUROCIRURGIAO CHEGA
  7. Chanson P, 2001, J CLIN ENDOCR METAB, V86, P3009, DOI 10.1210/jc.86.7.3009
  8. Clements CJ, 2003, DRUG SAFETY, V26, P599, DOI 10.2165/00002018-200326090-00001
  9. DArgenio P, 1996, VACCINE, V14, P1289, DOI 10.1016/S0264-410X(96)00069-2
  10. Dash D, 2016, EPILEPSY RES, V125, P19, DOI 10.1016/j.eplepsyres.2016.04.004
  11. Dawit S, 2019, NEUROLOGY, V92, pE2064, DOI 10.1212/WNL.0000000000007372
  12. Doyle YG, 2006, J EPIDEMIOL COMMUN H, V60, P396, DOI 10.1136/jech.2005.042770
  13. Dreger R, 1992, BRIT COLUMBIA HLTH D, V1, P50
  14. Fahn S, 2006, NEUROL REF SER, P24
  15. Fisher RS, 2017, EPILEPSIA, V58, P522, DOI 10.1111/epi.13670
  16. Friedman DE, 2009, J CLIN NEUROPHYSIOL, V26, P213, DOI 10.1097/WNP.0b013e3181b2f2da
  17. Gold MS, 2020, VACCINE, V38, P3025, DOI 10.1016/j.vaccine.2020.02.046
  18. Guerrini R, 2015, EPILEPSIA, V56, P1669, DOI 10.1111/epi.13200
  19. Han K, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002862
  20. Hanley SJB, 2015, LANCET, V385, P2571, DOI 10.1016/S0140-6736(15)61152-7
  21. Kharabsheh S, 2001, B WORLD HEALTH ORGAN, V79, P764
  22. Khiem HB, 2003, VACCINE, V21, P4527, DOI 10.1016/S0264-410X(03)00498-5
  23. Kurcgant D., 2019, MANUAL PRATICO NEURO, P115
  24. LaFrance WC, 2013, EPILEPSIA, V54, P2005, DOI 10.1111/epi.12356
  25. LaFrance WC, 2013, EPILEPSIA, V54, P53, DOI 10.1111/epi.12106
  26. Loharikar A, 2018, VACCINE, V36, P299, DOI 10.1016/j.vaccine.2017.11.017
  27. Marchetti RL, 2010, ARQ NEURO-PSIQUIAT, V68, P168, DOI 10.1590/S0004-282X2010000200003
  28. Marchetti RL, MANUAL PRATICO NEURO
  29. Martins S., 2019, MED USP AFIRMA QUE V
  30. Melo R., 2018, APOS DENUNCIAQUE VAC
  31. Miao Liang, 2010, Zhonghua Yu Fang Yi Xue Za Zhi, V44, P884
  32. Ministerio da Saude-Instituto Nacional de Cancer Jose Alencar Gomes da Silva, 2020, EST 2020 INC CANC BR
  33. Ministerio Publico do Estado do Acre, 2018, MPAC AC CAS ENV POSS
  34. Mullen SA, 2018, EPILEPSIA, V59, P1148, DOI 10.1111/epi.14042
  35. Oreskes N., 2019, WHY TRUST SCI U CTR
  36. Palacios R, 2014, COLOMB MEDICA, V45, P136
  37. Peiro EF, 1996, MED CLIN-BARCELONA, V107, P1
  38. Popkirov S, 2015, SEIZURE-EUR J EPILEP, V31, P124, DOI 10.1016/j.seizure.2015.07.016
  39. Ramanujam B, 2018, SEIZURE-EUR J EPILEP, V62, P95, DOI 10.1016/j.seizure.2018.10.003
  40. Reuber M, 2003, EPILEPSY BEHAV, V4, P205, DOI 10.1016/S1525-5050(03)00104-5
  41. Rose G, 2001, INT J EPIDEMIOL, V30, P427, DOI 10.1093/ije/30.3.427
  42. Scheffer IE, 2017, EPILEPSIA, V58, P512, DOI 10.1111/epi.13709
  43. Simas C, 2019, HUM VACC IMMUNOTHER, V15, P163, DOI 10.1080/21645515.2018.1511667
  44. Sirois F, 1974, Acta Psychiatr Scand Suppl, V252, P1
  45. Suppli CH, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6268-x
  46. Tatum WO, 2020, JAMA NEUROL, V77, P593, DOI 10.1001/jamaneurol.2019.4785
  47. Verbeek NE, 2014, PEDIATRICS, V134, P658, DOI 10.1542/peds.2014-0690
  48. WESSELY S, 1987, PSYCHOL MED, V17, P109, DOI 10.1017/S0033291700013027
  49. World Health Organization, 2019, 10 THREATS GLOB HLTH
  50. World Health Organization, 2019, IMM STRESS REL RESP
  51. World Health Organization, 2010, ICD10 WHO
  52. World Health Organization, 2017, SAF UPD HPV VACC
  53. WYLER AR, 1993, NON-EPILEPTIC SEIZURES, P73
  54. Yasamy M T, 1999, East Mediterr Health J, V5, P710
  55. ZOUAOUI A, 1988, ACTA ANAT, V133, P318